A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury

BACKGROUND: To assess the effect of botulinum toxin A (BTA) for treating neuropathic pain in patients with spinal cord injury (SCI). METHODS: A total of 44 patients with SCI with neuropathic pain were randomly divided into the intervention group and the placebo group, each group 21 patients. The sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Gang, Lv, Chang-an, Tian, Li, Jin, Lian-jin, Sun, Ping, Zhao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440146/
https://www.ncbi.nlm.nih.gov/pubmed/28514309
http://dx.doi.org/10.1097/MD.0000000000006919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440146/
https://www.ncbi.nlm.nih.gov/pubmed/28514309
http://dx.doi.org/10.1097/MD.0000000000006919

Ejemplares similares